Literature DB >> 22966880

The miRNA-drug resistance connection: a new era of personalized medicine using noncoding RNA begins.

Prasun J Mishra.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22966880      PMCID： PMC3464977          DOI： 10.2217/pgs.12.121

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN： 1462-2416            Impact factor:   2.533


× No keyword cloud information.
  37 in total

1.  A vision for the future of genomics research.

Authors:  Francis S Collins; Eric D Green; Alan E Guttmacher; Mark S Guyer
Journal:  Nature       Date:  2003-04-14       Impact factor: 49.962

2.  An extensive class of small RNAs in Caenorhabditis elegans.

Authors:  R C Lee; V Ambros
Journal:  Science       Date:  2001-10-26       Impact factor: 47.728

3.  Tumor microRNA expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patients.

Authors:  Ram Eitan; Michal Kushnir; Gila Lithwick-Yanai; Miriam Ben David; Moshe Hoshen; Marek Glezerman; Moshe Hod; Gad Sabah; Shai Rosenwald; Hanoch Levavi
Journal:  Gynecol Oncol       Date:  2009-05-14       Impact factor: 5.482

4.  Role of microRNAs in drug-resistant ovarian cancer cells.

Authors:  Antonio Sorrentino; Chang-Gong Liu; Antonio Addario; Cesare Peschle; Giovanni Scambia; Cristiano Ferlini
Journal:  Gynecol Oncol       Date:  2008-09-26       Impact factor: 5.482

5.  Unique microRNA molecular profiles in lung cancer diagnosis and prognosis.

Authors:  Nozomu Yanaihara; Natasha Caplen; Elise Bowman; Masahiro Seike; Kensuke Kumamoto; Ming Yi; Robert M Stephens; Aikou Okamoto; Jun Yokota; Tadao Tanaka; George Adrian Calin; Chang-Gong Liu; Carlo M Croce; Curtis C Harris
Journal:  Cancer Cell       Date:  2006-03       Impact factor: 31.743

6.  microRNA-205 regulates HER3 in human breast cancer.

Authors:  Marilena V Iorio; Patrizia Casalini; Claudia Piovan; Gianpiero Di Leva; Andrea Merlo; Tiziana Triulzi; Sylvie Ménard; Carlo M Croce; Elda Tagliabue
Journal:  Cancer Res       Date:  2009-03-10       Impact factor: 12.701

7.  miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells.

Authors:  Lin Xia; Dexin Zhang; Rui Du; Yanglin Pan; Lina Zhao; Shiren Sun; Liu Hong; Jie Liu; Daiming Fan
Journal:  Int J Cancer       Date:  2008-07-15       Impact factor: 7.396

8.  Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells.

Authors:  Hua Zhu; Hao Wu; Xiuping Liu; Brad R Evans; Daniel J Medina; Chang-Gong Liu; Jin-Ming Yang
Journal:  Biochem Pharmacol       Date:  2008-06-24       Impact factor: 5.858

Review 9.  MiRSNPs or MiR-polymorphisms, new players in microRNA mediated regulation of the cell: Introducing microRNA pharmacogenomics.

Authors:  Prasun J Mishra; Pravin J Mishra; Debabrata Banerjee; Joseph R Bertino
Journal:  Cell Cycle       Date:  2008-01-28       Impact factor: 4.534

10.  MicroRNAs modulate the chemosensitivity of tumor cells.

Authors:  Paul E Blower; Ji-Hyun Chung; Joseph S Verducci; Shili Lin; Jong-Kook Park; Zunyan Dai; Chang-Gong Liu; Thomas D Schmittgen; William C Reinhold; Carlo M Croce; John N Weinstein; Wolfgang Sadee
Journal:  Mol Cancer Ther       Date:  2008-01-09       Impact factor: 6.261
View more
  18 in total

1.  Refugia and the evolutionary epidemiology of drug resistance.

Authors:  Andrew W Park; James Haven; Ray Kaplan; Sylvain Gandon
Journal:  Biol Lett       Date:  2015-11       Impact factor: 3.703

2.  The expression, induction and pharmacological activity of CYP1A2 are post-transcriptionally regulated by microRNA hsa-miR-132-5p.

Authors:  Yinting Chen; Linjuan Zeng; Yong Wang; William H Tolleson; Bridgett Knox; Si Chen; Zhen Ren; Lei Guo; Nan Mei; Feng Qian; Kaihong Huang; David Liu; Weida Tong; Dianke Yu; Baitang Ning
Journal:  Biochem Pharmacol       Date:  2017-08-16       Impact factor: 5.858

Review 3.  Review of microRNA in osteosarcoma and chondrosarcoma.

Authors:  Le Chang; Swati Shrestha; Greg LaChaud; Michelle A Scott; Aaron W James
Journal:  Med Oncol       Date:  2015-04-26       Impact factor: 3.064

4.  Promoter demethylation of nuclear factor-erythroid 2-related factor 2 gene in drug-resistant colon cancer cells.

Authors:  Xiao-Qian Zhao; Yi-Fei Zhang; Yi-Fang Xia; Zhong-Mei Zhou; Ying-Qing Cao
Journal:  Oncol Lett       Date:  2015-07-08       Impact factor: 2.967

5.  Non-coding RNAs as clinical biomarkers for cancer diagnosis and prognosis.

Authors:  Prasun J Mishra
Journal:  Expert Rev Mol Diagn       Date:  2014-11       Impact factor: 5.225

6.  A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells.

Authors:  Annamaria Gullà; Maria Teresa Di Martino; Maria Eugenia Gallo Cantafio; Eugenio Morelli; Nicola Amodio; Cirino Botta; Maria Rita Pitari; Santo Giovanni Lio; Domenico Britti; Maria Angelica Stamato; Teru Hideshima; Nikhil C Munshi; Kenneth C Anderson; Pierosandro Tagliaferri; Pierfrancesco Tassone
Journal:  Clin Cancer Res       Date:  2015-11-02       Impact factor: 12.531

7.  A long non-coding RNA snaR contributes to 5-fluorouracil resistance in human colon cancer cells.

Authors:  Heejin Lee; Chongtae Kim; Ja-Lok Ku; Wook Kim; Sungjoo Kim Yoon; Hyo-Jeong Kuh; Jeong-Hwa Lee; Suk Woo Nam; Eun Kyung Lee
Journal:  Mol Cells       Date:  2014-07-31       Impact factor: 5.034

Review 8.  Tumor-Associated CSF MicroRNAs for the Prediction and Evaluation of CNS Malignancies.

Authors:  Tarek Shalaby; Michael A Grotzer
Journal:  Int J Mol Sci       Date:  2015-12-07       Impact factor: 5.923

Review 9.  Post-transcriptional controls by ribonucleoprotein complexes in the acquisition of drug resistance.

Authors:  Hoin Kang; Chongtae Kim; Heejin Lee; Wook Kim; Eun Kyung Lee
Journal:  Int J Mol Sci       Date:  2013-08-20       Impact factor: 5.923

Review 10.  Non-coding RNAs in muscle dystrophies.

Authors:  Daniela Erriquez; Giovanni Perini; Alessandra Ferlini
Journal:  Int J Mol Sci       Date:  2013-09-30       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.